跳至主要内容
临床试验/CTRI/2010/091/001095
CTRI/2010/091/001095进行中(未招募)未知

Randomized, double blind, placebo controlled trial to compare the efficacy of 3-months versus 6-months therapy with prednisolone for the first episode of idiopathic nephrotic syndrome in children - None

Indian Council of Medical Research0 个研究点目标入组 168 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
168

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with idiopathic, steroid sensitive nephrotic syndrome
  • 2. First episode of nephrotic syndrome
  • 3. Age 1 to 12 years

排除标准

  • 1.Nephrotic syndrome known to be secondary to a systemic disorder, e.g., IgA nephropathy, systemic lupus erythematosus, Henoch Schonlein purpura, vasculitis, amyloidosis, hepatitis B antigenemia and Alport syndrome.
  • 2.Patients with impaired renal functions (serum creatinine > 1.2 mg/dl, confirmed within 2 weeks)
  • 3.Patients who have received oral prednisolone, in the past for nephrotic syndrome
  • 4.Patients who have taken prednisolone in the past 4 weeks, in a dose more than 1 mg/kg for >10 days for any other reason
  • 5.Unclear treatment history.
  • 6.Patients staying more than 100 km from the Institute or those not willing to come for clinic visits every two months
  • 7.Gross hematuria
  • 8.Patients with initial steroid resistance
  • 9.Patients who show relapse within the first 3 months of therapy.

研究者

相似试验

A clinical trial to compare the effectiveness and... | 临床试验